Abstract
We report a case of two patients with foot drop due to peroneal nerve infarct as early sign of two different forms of primary systemic vasculitides: a predominantly small-vessel p-antineutrophil cytoplasmic antibody-positive vasculitis (microscopic polyangiitis) and a predominantly medium-vessel vasculitis (polyarteritis nodosa).
Background
Systemic vasculitis is a disease that should be treated vigorously because of its tumultuous evolution. Clinical features of systemic vasculitides are determined by location and size of the affected vessels, severity of the inflammatory process and comorbid conditions.1
The diagnostic process is sometimes challenging because of the presentation with aspecific signs (fever, loss of weight, sweating) that are later followed by progressive multiple organ involvement (kidney, lung, gut and peripheral nerves).
Overall, in about 25% of patients with systemic vasculitis,2–4 the vasa nervorum infarcts due to occlusion of small epineuronial arteries lead to acute or subacute axonal painful and multifocal neuropathy, which is an important alert for neurologists.5
However, the rate of neuropathic complications varies among the different types of systemic vasculitis, because at baseline it occurs in about 10% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis,6 whereas this percentage is higher in advanced cases, that is, 45% in microscopic polyangiitis, in a recent series,7 8 and 60–70% in polyarteritis nodosa (PAN).9
Case presentation
Case 1
A 52-year-old man, who had been on a holiday in North Africa 2 months before, started to suffer from high fever unresponsive to antibiotics. He lost 5 kg in 6 weeks and was referred to the infectious diseases department. Few days after hospitalisation, he experienced tingling in the four extremities and became unable to walk because of a bilateral food drop. The neurological examination documented mild weakness in the upper limbs (Medical Research Council (MRC) scale 4/5 in proximal muscles and 3/5 in distal muscles) and severe weakness in the lower limbs, with asymmetric and distal-dominant distribution (MRC 3/5 leg flexors, 2/5 right tibialis anterior and right extensor digitorum brevis), absence of deep tendon reflexes in the lower limbs, stocking-gloves hypoesthesia and reduced distal vibratory sense. During the next few weeks, the patient developed severe peripheral oedema due to acute kidney failure.
Case 2
A 46-year-old man was hospitalised in the urology department because of an acute orchialgia with the clinical suspect for infectious orchitis. The epididimous was removed (figure 1), but no pyogenous or mycotic infection was detected, although he had constant fever and leukocytosis. The patient started to suffer from numbness and tingling in the lower limbs, and after 2 weeks, suddenly a right foot drop (preceded by acute pain in the leg) appeared; therefore, the patient was transferred to the neurology department. Ankle reflexes were absent in the lower limbs and the patient reported distal stocking hypoesthesia. The distal strength worsened in few days, preventing the patient to bilaterally move his feet (MRC 0/5 in foot dorsiflexion). Few days later, the pain involved the abdomen and an emergency surgical operation was required because of peritonitis.
Figure 1.

Testis tissue from patient 2. On the right, vasculitic infiltrates (→)with fibrinoid necrosis (*) can be appreciated. The wall of small-sized and medium-sized arteries showing necrotising and hyaline degeneration and the inner elastic lamina is destroyed, leading to complete vessel occlusion. On the left, a peripheral nerve is surrounded by inflammatory cells (○) (H&E, ×200).
Investigations
On admission, patient 1 had C reactive protein (CRP) 15 mg/dL, leukocytosis (white cell count (WCC) 13 000 /µL; eosinophils 500 /µL), rheumatoid factor 103 mg/dL, normal complement dosage (C3, C4), perinuclear antibodies directed against cytoplasmic protein antigens in neutrophils and monocytes10 (p-ANCAs) 423, HCV-abs positivity, proteinuria (>1.5 g/die) and small size pulmonary infiltrates (figure 2). Cerebrospinal fluid protein levels and cell counts were normal.
Figure 2.

Chest X-ray of patient 1 on admission. Diffuse bilateral small-vessel infiltrates can be appreciated.
Patient 2 had erythrocyte sedimentation rates 95 mm/h, CRP 20 mg/dL, leucocytosis (WCC 10 000), increased β2-microglobulin and monoclonal gammopathy (detected at serum protein electrophoresis), but serum immunofixation and Bence-Jones protein were negative. Serological screening for HIV, HCV and HBV was negative.
The electromyography (EMG) recordings in both cases showed a severe axonal multineuropathy with patchy distribution (figure 3). Motor and sensory peripheral nerves of the upper and lower limbs were asymmetrically involved (eg, ulnar nerve on one side and tibial or peroneal nerve on the other side). Compound muscle action potentials (CMAPs) were deeply reduced, whereas the conduction velocities and distal latencies were preserved. This pattern was consistent with multiplex axonal degeneration of nerve fibres caused by ischaemia.
Figure 3.
Neurophysiological recordings from patient 1 in the acute phase. (A) The left peroneal nerve study showing undetectable compound muscle action potentials (CMAPs) at ankle and popliteal fossa recording from extensor digitorum brevis (EBD) muscle and still evocable, but very low amplitude CMAPs recording from tibialis anterior (TA) muscle. (B) The right ulnar nerve study, recording from abductor digiti minimi (ADM) muscle, showing very low amplitude CMAPs at distal and proximal stimulation sites. The severe decrease in amplitude is not coupled with a reduction of conduction velocity. Fibrillation potentials were recorded with concentric EMG needle in peroneal innervated muscles (EBD and TA) and in ulnar innervated muscles (ADM, first dorsal interosseous or FDI), suggesting prominent denervation due to a severe and acute axonal multiplex mononeuropathy. Sensory nerve action potentials of the left median, the right and left sural, and the right ulnar nerve had very low amplitude as well (not represented).
For patient 1, a kidney biopsy (figure 4) and a right sural nerve biopsy (figure 5) were performed and led us to diagnose definite microscopic polyangiitis (MPA) according to the Peripheral Nerve Society criteria for systemic vasculitic neuropathy.11
Figure 4.

Kidney biopsy from patient 1. Typical features of microscopic polyangiitis are shown in (A): destruction of the internal elastic lamina of an artery and fibrocellular crescent in a glomerulus (+). In the Masson's trichrome staining (B) fibrinoid necrosis of a glomerulus is shown at higher magnification ((A) H&E, ×200; (B) Masson's trichrome staining, ×400).
Figure 5.
Sural nerve biopsy of patient 1. (A) Peripheral nerve biopsy showing vasculitic infiltrates that consist predominantly of T lymphocytes stained by anti-CD3 antibodies ((A) H&E, ×200; (B) and (C) CD3 staining, ×400 and ×600, respectively).
For patient 2, the histological analysis of tissues removed after surgical operations (testis and bowel) was diagnostic of PAN.
Differential diagnosis
In both cases, high fever was the first symptom and was initially related to an infectious cause, unresponsive to antibiotics. For patient 1, a tropical infection was suspected. For patient 2, instead, lymphoma was initially compatible with laboratory examinations, but this diagnosis was excluded after positron emission tomography-total body and osteomedullary biopsy.
Vasculitis could mimic many diseases because of the multiorgan involvement, but in our cases the clinical sign that essentially led to diagnosis was peripheral neuropathy.
The involvement of peroneal nerve occurs more frequently than others,4 followed by sural and tibial nerve. The pain localised in the area of affected nerve is also typical, as experienced by our patients.
Treatment
As soon as the diagnosis was confirmed by histological analysis, in both cases, high-dose intravenous steroids (methylprednisolone 1 g for 10 days) were started and followed by intravenously pulsed cyclophosphamide (6 cycles at the standard dose of 500 mg/m2). According to the Chaper Hill criteria,1 both patients received intravenous high-dose steroids and a prolonged immunosuppression of oral steroids combined with immunosuppressive agents (azathioprine and then mycophenolate mofetil in patient 1, cyclophosphamide in patient 2). Both patients started intense physiokinesitherapy before being discharged.
Outcome and follow-up
Although the hospitalisation of patient 2 was complicated by a bowel perforation that required intensive care unit monitoring, both patients had an overall good long-term prognosis as described in the literature,12 with a partial neurological improvement. They started to walk unassisted after few months and are still performing physiokinesitherapy, but remained slightly disabled; the effect of axonal damage is still detectable with EMG recordings after more than 2 years. Both patients receive periodically clinical and neurophysiological follow-up, with constant control of p-ANCA antibodies and kidney function for patient 1.
Discussion
Certain nerves have a propensity for vasculitic involvement, probably due to their poor collateral vessel supply. The most frequently affected individual nerve is the common peroneal nerve.13 In MPA, the ischaemic zone that directly damages nerve fibres is present in the proximal-middle portion of peripheral nerve trunks.14
In a large cohort of patients with ANCA, called EUVAS trial, no correlation could be found between peripheral neuropathy at diagnosis and the occurrence of life-threatening organ involvement (chest, renal, cardiovascular and abdominal).6 During the first 5 years after diagnosis of granulomatosis with polyangiitis and MPA, 15% of patients developed chronic peripheral neuropathy lasting over 3 months.6
Although nerve involvement is not life-threatening, it can impair the quality of life of patients because of weakness or pain in the extremities.15
Learning points.
Peripheral nerve involvement with an axonal patchy pattern (mononeuritis multiplex) should raise a suspicion of a vasculitis, a life-threatening disorder that needs urgent treatment.
Histological confirmation is strongly recommended because escalating immunosuppressive treatments are needed and prolonged for a long time.
Peroneal nerve involvement is a classical feature of small-vessel and medium-vessel vasculitis as microscopic polyangiitis and polyarteritis nodosa.
Acknowledgments
The authors thank Professor Renzo Boldorini, pathologist, for his help in the diagnostic procedure (biopsies).
Footnotes
Contributors: PR acquired and analysed the data, wrote and edited the manuscript and approved the final version. CV and RC contributed to acquisition and analysis of the data, revision of the draft for important intellectual content and final approval of the manuscript. EM contributed to analysis of the data (biopsies), revision of the draft for important intellectual content and final approval of the manuscript.
Competing interests: None.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1–11 [DOI] [PubMed] [Google Scholar]
- 2.Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 2005;17:41–8 [DOI] [PubMed] [Google Scholar]
- 3.Collins MP, Arnold WD, Kissel JT. The neuropathies of vasculitis. Neurol Clin 2013;31:557–95 [DOI] [PubMed] [Google Scholar]
- 4.Wolf J, Schmitt V, Palm F, et al. Peripheral neuropathy as initial manifestation of primary systemic vasculitides. J Neurol 2013;260:1061–70 [DOI] [PubMed] [Google Scholar]
- 5.Scully EP, Klompas M, Morgan EA, et al. Clinical problem-solving. Waiting for the other foot to drop. N Engl J Med 2013;368:2220–5 [DOI] [PubMed] [Google Scholar]
- 6.Suppiah R, Hadden RD, Batra R, et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 2011;50:2214–22 [DOI] [PubMed] [Google Scholar]
- 7.Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421–30 [DOI] [PubMed] [Google Scholar]
- 8.Zhang W, Zhou G, Shi Q, et al. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 2009;27(1 Suppl 52):S65–9 [PubMed] [Google Scholar]
- 9.Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010;62:616–26 [DOI] [PubMed] [Google Scholar]
- 10.Wiik AS. Autoantibodies in ANCA-associated vasculitis. Rheum Dis Clin North Am 2010;36:479–89 [DOI] [PubMed] [Google Scholar]
- 11.Collins MP, Dyck PJ, Gronseth GS, et al. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010;15:176–84 [DOI] [PubMed] [Google Scholar]
- 12.Gayraud M, Guillevin L, le Toumelin P, et al. Long-term follow up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666–75 [DOI] [PubMed] [Google Scholar]
- 13.Bennett DL, Groves M, Blake J, et al. The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5year retrospective study. J Neurol Neurosurg Psychiatry 2008;79:1376–81 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Morozumi S, Koike H, Tomita M, et al. Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J Neuropathol Exp Neurol 2011;70:340–8 [DOI] [PubMed] [Google Scholar]
- 15.Walsh M, Mukhtyar C, Mahr A, et al. Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken) 2011;63:1055–61 [DOI] [PMC free article] [PubMed] [Google Scholar]


